huperzine A high dose
Selected indexed studies
- Dissolving microneedles for transdermal delivery of huperzine A for the treatment of Alzheimer's disease. (Drug Deliv, 2020) [PMID:32729341]
- Huperzine A ameliorates obesity-related cognitive performance impairments involving neuronal insulin signaling pathway in mice. (Acta Pharmacol Sin, 2020) [PMID:31213670]
- The NMDA receptor ion channel: a site for binding of Huperzine A. (J Appl Toxicol, 2001) [PMID:11920920]
_Worker-drafted node — pending editorial review._
Connections
huperzine A high dose protects against
Sources
- Dissolving microneedles for transdermal delivery of huperzine A for the treatment of Alzheimer's disease. (2020) pubmed
- Huperzine A ameliorates obesity-related cognitive performance impairments involving neuronal insulin signaling pathway in mice. (2020) pubmed
- The NMDA receptor ion channel: a site for binding of Huperzine A. (2001) pubmed
- Pharmacokinetics of huperzine A following oral administration to human volunteers. (2007) pubmed
- Pharmacokinetics of tablet huperzine A in six volunteers. (1995) pubmed
- A combination of [+] and [-]-Huperzine A improves protection against soman toxicity compared to [+]-Huperzine A in guinea pigs. (2013) pubmed
- Safety and Preliminary Efficacy of the Acetylcholinesterase Inhibitor Huperzine A as a Treatment for Cocaine Use Disorder. (2015) pubmed
- Huperzine A ameliorates cognitive deficits and oxidative stress in the hippocampus of rats exposed to acute hypobaric hypoxia. (2012) pubmed
- Intoxication with huperzine A, a potent anticholinesterase found in the fir club moss. (2000) pubmed
- Huperzine A in rat plasma and CSF following intranasal administration. (2007) pubmed